Press-release for stocks publishing date 2022 - 03

Prices are updated after-hours

Sanofi, AstraZeneca Express Optimism Over Phase III Infant RSV Results
Published: 2022-03-03 (Crawled : 14:30) - biospace.com/
SNYNF | News | $94.25 480

| -9.98% | O: -6.92% H: 1.86% C: 1.86%
SNY | News | $46.765 -1.94% 1.2M

| -6.65% | O: 0.18% H: 0.0% C: 0.0%
results ism

Dyne Therapeutics Appoints Carlo Incerti, M.D., to its Board of Directors
Published: 2022-03-03 (Crawled : 13:30) - biospace.com/
SNYNF | News | $94.25 480

| -9.98% | O: -6.92% H: 1.86% C: 1.86%
SNY | News | $46.765 -1.94% 1.2M

| -6.65% | O: 0.18% H: 0.0% C: 0.0%
DYN | $25.24 -0.79% 330K

| 190.91% | O: 0.74% H: 2.72% C: -4.65%
therapeutics

Nirsevimab significantly protected infants against RSV disease in Phase 3 trial
Published: 2022-03-03 (Crawled : 09:00) - biospace.com/
SNYNF | News | $94.25 480

| -9.98% | O: -6.92% H: 1.86% C: 1.86%
SNY | News | $46.765 -1.94% 1.2M

| -6.65% | O: 0.18% H: 0.0% C: 0.0%
trial disease phase 3

58%

42%

CSSE 4 | $0.3831 151.54% 190M

CZOO | $11.04 121.24% 11M

LICN | $0.9107 62.63% 14M

BOF | $1.87 59.83% 100M

AMST | $3.18 59.0% 67M

SKIL 4 | $8.72 52.72% 410K

MTC | $3.31 47.77% 7.7M

MULN | News | $3.915 43.41% 12M

WIMI | $1.04 43.37% 17M

RILY | $29.755 36.99% 12M

Save your searches and get alerts when important news are released.